Connective tissue disorders. systemic lupus erythematosus, Sjögren's syndrome, and scleroderma.

Handbook of Clinical Neurology

Volumn 119, Issue , 2014, Pages 463-473

  Streifler, Jonathan Y ^a   Molad, Yair ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Antiphospholipid syndrome; Connective tissue disorders; Multisystem rheumatic disorders; Neuropsychiatric manifestations; Peripheral nervous system manifestations; Scleroderma; Sj gren's syndrome; Systemic autoimmune disorders; Systemic lupus erythematosus

Indexed keywords

ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CONNECTIVE TISSUE DISEASE; CONNECTIVE TISSUE DISORDERS; HUMAN; MULTISYSTEM RHEUMATIC DISORDERS; NEUROLOGIC DISEASE; NEUROPSYCHIATRIC MANIFESTATIONS; PERIPHERAL NERVOUS SYSTEM MANIFESTATIONS; SCLERODERMA; SJOEGREN SYNDROME; SJÖGREN'S SYNDROME; SYSTEMIC AUTOIMMUNE DISORDERS; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

ANTIPHOSPHOLIPID SYNDROME; CONNECTIVE TISSUE DISORDERS; MULTISYSTEM RHEUMATIC DISORDERS; NEUROPSYCHIATRIC MANIFESTATIONS; PERIPHERAL NERVOUS SYSTEM MANIFESTATIONS; SCLERODERMA; SJÖGREN'S SYNDROME; SYSTEMIC AUTOIMMUNE DISORDERS; SYSTEMIC LUPUS ERYTHEMATOSUS;

CONNECTIVE TISSUE DISEASES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; NERVOUS SYSTEM DISEASES; SCLERODERMA, SYSTEMIC; SJOGREN'S SYNDROME;

EID: 84890877350     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-7020-4086-3.00030-8     Document Type: Chapter

References (72)

1. ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999, 42:599-608.
2. Ainiala H. Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation. Arthritis Rheum 2001, 45:419-423.
3. Alexander E.L., Alexander G.E. Aseptic meningoencephalitis in primary Sjögren's syndrome. Neurology 1983, 33:593-598.
4. Alexander E.L., Provost T.T., Stevens M.B., et al. Neurologic complications of primary Sjögren's syndrome. Medicine 1982, 61:247-257.
5. Alexander E.L., Malinow K., Lejewski J.E. Primary Sjögren's syndrome with central nervous system disease mimicking multiple sclerosis. Ann Intern Med 1986, 104:323-330.
6. Amor-Dorado J.C., Barreira-Fernandez M.P., Arias-Nuñez M.C., et al. Benign paroxysmal positional vertigo and clinical test of sensory interaction and balance in systemic sclerosis. Otol Neurotol 2008, 29:1155-1161.
7. Andonopoulos A.P., Christodoulou J., Ballas C., et al. Autonomic cardiovascular neuropathy in Sjögren's syndrome, a controlled study. J Rheumatol 1998, 25:2385-2388.
8. Averbuch-Heller L., Steiner I., Abramsky O. Neurologic manifestations of progressive systemic sclerosis. Arch Neurol 1992, 49:1292-1295.
9. Bertsias G.K., Salmon J.E., Boumpas D.T. Therapeutic opportunities in systemic lupus erythematosus: state of the art and prospects for the new decade. Ann Rheum Dis 2010, 69:1603-1611.
10. Bertsias G.K., Ioannidis J.P., Aringer M., et al. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis 2010, 69:2074-2082.
11. Boutry N., Hachulla E., Zanetti-Musielak C., et al. Imaging features of musculoskeletal involvement in systemic sclerosis. Eur Radiol 2007, 17:1172-1180.
12. Bruns A., Meyer O. Neuropsychiatric manifestations of systemic lupus erythematosus. Joint Bone Spine 2006, 73:639-645.
13. Cervera R. Catastrophic antiphospholipid syndrome (CAPS): update from the "CAPS Registry". Lupus 2010, 19:412-418. CAPS Registry Project Group.
14. Clements P.J., Furst D.E., Campion D.S., et al. Muscle disease in progressive systemic sclerosis. Arthritis Rheum 1978, 21:62-71.
15. Cohen D., Berger S.P., Steup-Beekman G.M., et al. Diagnosis and management of the antiphospholipid syndrome. BMJ 2010, 340:1125-1132.
16. Corbo M., Nemni R., Iannaccone S., et al. Peripheral neuropathy in scleroderma. Clin Neuropathol 1993, 12:63-67.
17. D'Cruz D.P., Khamashta M.A., Hughes G.R.V. Systemic lupus erythematosus. Lancet 2007, 369:587-596.
18. Deroee A.F., Huang T.C., Morita N., et al. Sudden hearing loss as the presenting symptom of systemic sclerosis. Otol Neurotol 2009, 30:277-279.
19. Delalande S., de Seze J., Fauchais A.L., et al. Neurologic manifestations in primary Sjögren's syndrome: a study of 82 patients. Medicine 2004, 83:280-291.
20. De Seze J., Stojkovic T., Hachulla E., et al. Myelopathy-Sjögren's syndrome association: analysis of clinical and radiological findings and clinical course. Rev Neurol 2001, 157:669-678.
21. Dessein P.H., Joffe B.I., Metz R.M., et al. Autonomic dysfunction in systemic sclerosis: sympathetic overactivity and instability. Am J Med 1992, 93:143-150.
22. Diamond B. Antibodies and the brain: lessons from lupus. J Immunol 2010, 185:2637-2640.
23. Di Franco M., Paradiso M., Riccieri V., et al. Autonomic dysfunction and microvascular damage in systemic sclerosis. Clin Rheumatol 2007, 26:1278-1283.
24. Eric J., Boren A., Gurtej S., et al. The emergence of progressive multifocal leukoencephalopathy (PML) in rheumatic diseases. J Autoimmun 2008, 30:90-98.
25. Fernandez-Nebro A. Chronic or recurrent headache in patients with systemic lupus erythematosus: a case control study. Lupus 1999, 8:151-156.
26. Garcin B., Lenglet T., Dubourg O., et al. Dropped head syndrome as a presenting sign of scleromyositis. J Neurol Sci 2010, 292:101-103.
27. Gordon R., Silverstein A. Neurologic manifestations in progressive systemic sclerosis. Arch Neurol 1970, 22:126-134.
28. Griffin J.W., Cornblath D.R., Alexander E., et al. Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sjögren's syndrome. Ann Neurol 1990, 27:304-315.
29. Hanly J.G. Neuropsychiatric lupus. Rheum Dis Clin North Am 2005, 31:273-298.
30. Hanly J.G., Urowitz M.B., Sanchez-Guerrero J., et al. Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. Arthritis Rheum 2007, 56:265-273.
31. Hanly J.G., Su L., Farewell V., et al. Prospective study of neuropsychiatric events in systemic lupus erythematosus. J Rheumatol 2009, 36:1449-1459.
32. Hanly J.G., Urowitz M.B., Su L., et al. Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus. Ann Rheum Dis 2010, 69:529-535.
33. Héron E., Fornes P., Rance A. Brain involvement in scleroderma: two autopsy cases. Stroke 1998, 29:719-721.
34. Hietaharju A., Jääskeläinen S., Kalimo H. Peripheral neuromuscular manifestations of systemic sclerosis (scleroderma). Muscle Nerve 1993, 16:1204-1212.
35. Ioannidis J.P., Vlachoyiannopoulos P.G., Haidich A.B., et al. Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med 2005, 118:2-10.
36. Kazuyuki I., Toshiki U., Hidehiro M. Recurrent aseptic meningitis: a new CSF complication of Sjögren's syndrome. J Neurol 2007, 254:806-807.
37. Lafitte C. Neurological manifestations in Sjögren syndrome. Arch Neurol 2000, 57:411-413.
38. Lee P., Bruni J., Sukenik S. Neurological manifestations in systemic sclerosis (scleroderma). J Rheumatol 1984, 11:480-483.
39. Leinwand I., Duryee W., Richter M.N. Scleroderma (based on a study of over 150 cases). Ann Intern Med 1954, 41:1003-1141.
40. Mahler M., Kessenbrock K., Szmyrka M., et al. International multi-center evaluation of autoantibodies to ribosomal P proteins. Clin Vaccine Immunol 2006, 13:77-83.
41. Malinow K., Yannakakis G.D., Glusman S.M., et al. Subacute sensory neuronopathy secondary to dorsal root ganglionitis in primary Sjögren's syndrome. Ann Neurol 1986, 20:535-537.
42. Mayes M.D. Scleroderma epidemiology. Rheum Dis Clin North Am 2003, 29:239-254.
43. Medsger T.A. Natural history of systemic sclerosis and the assessment of disease activity, severity, functional status and psychologic well-being. Rheum Dis Clin North Am 2003, 29:255-273.
44. Mikdashi J., Handwerger B. Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort. Rheumatology 2004, 43:1555-1560.
45. Mok C.C., To C.H., Mak A. Neuropsychiatric damage in southern Chinese patients with systemic lupus erythematosus. Medicine 2006, 85:221-228.
46. Molad Y., Gorshtein A., Wysenbeek A.J., et al. Protective effect of hydroxychloroquine in systemic lupus erythematosus: prospective long-term study of an Israeli cohort. Lupus 2002, 11:356-361.
47. Molloy E.S., Calabrese L.H. Progressive multifocal leukoencephalopathy: a national estimate of frequency in systemic lupus erythematosus and other rheumatic diseases. Arthritis Rheum 2009, 60:3761-3765.
48. Mori K., Iijima M., Koike H., et al. The wide spectrum of clinical manifestations in Sjögren's syndrome-associated neuropathy. Brain 2005, 128:2518-2534.
49. Muscal E., Brey R.L. Antiphospholipid syndrome and the brain in pediatric and adult patients. Lupus 2010, 19:406-411.
50. Nitta Y., Sobue G. Progressive systemic sclerosis associated with multiple mononeuropathy. Dermatology 1996, 193:22-26.
51. Nobuhara Y., Saito M., Goto R., et al. Chronic progressive sensory ataxic neuropathy associated with limited systemic sclerosis. J Neurol Sci 2006, 241:103-106.
52. Olazarán J., López-Longo J., Cruz I., et al. Cognitive dysfunction in systemic lupus erythematosus: prevalence and correlates. Eur Neurol 2009, 62:49-55.
53. Olsen N.J., King L.E., Park J.H. Muscle abnormalities in scleroderma. Rheum Dis Clin North Am 1996, 22:783-796.
54. Pathak R., Gabor A.J. Scleroderma and central nervous system vasculitis. Stroke 1991, 22:410-413.
55. Poncelet A.N., Connolly M.K. Peripheral neuropathy in scleroderma. Muscle Nerve 2003, 28:330-335.
56. Pun K.K., Wong C.K., Tsui E.Y., et al. Hypokalemic periodic paralysis due to the Sjögren syndrome in Chinese patients. Ann Intern Med 1989, 110:405-406.
57. Rahman A., Isenberg D.A. Systemic lupus erythematosus. N Eng J Med 2008, 358:929-939.
58. Rogers S.J., Williams C.S., Gustavo C.R. Myelopathy in Sjögren's syndrome. Role of nonsteroidal immunosuppressants. Drugs 2004, 64:123-132.
59. Rosato E., Rossi C., Salsano F. Dropped head syndrome and systemic sclerosis. Joint Bone Spine 2009, 76:301-303.
60. Rossi R., Saddi M.V. Subacute aseptic meningitis as neurological manifestation of primary Sjögren's syndrome. Clin Neurol Neurosurg 2006, 108:688-691.
61. Ruiz-Irastorza G., Ramos-Casals M., Brito-Zeron P., et al. Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Ann Rheum Dis 2010, 69:20-28.
62. Schieir O., Brett D., Thombs M.H., et al. Prevalence, severity, and clinical correlates of pain in patients with systemic sclerosis. Arthritis Care Res 2010, 62:409-417. and the Canadian Scleroderma Research Group.
63. Sibbitt W.L., Brooks W.M., Kornfeld M., et al. Magnetic resonance imaging and brain histopathology in neuropsychiatric systemic lupus erythematosus. Semin Arthritis Rheum 2010, 40:32-52.
64. Silver R.M. Clinical aspects of systemic sclerosis (scleroderma). Ann Rheum Dis 1991, 50:854-861.
65. Sisto M., Lisi S., Lofrumento D., et al. Autoantibodies from Sjögren's syndrome trigger apoptosis in salivary gland cell line. Ann N Y Acad Sci 2007, 1108:418-425.
66. Sjögren H. Zur Kenntnis der Keratoconjunctivitis sicca: Keratitis filiformis bei Hypofunktion der Tränendrüsen. Acta Ophthalmol 1933, 11(Suppl. 2):1-151.
67. Stojanovich L. Autonomic dysfunction in autoimmune rheumatic disease. Autoimmun Rev 2009, 8:569-572.
68. Tagliafico A., Panicob N., Resmini E., et al. The role of ultrasound imaging in the evaluation of peripheral nerve in systemic sclerosis (scleroderma). Eur J Radiol. 2011, 77:377-382.
69. Urowitz M.B., Gladman D., Ibañez D., et al. Systemic Lupus International Collaborating Clinics. Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2010, 62:881-887.
70. Vitali C., Bombardieri S., Jonsson R., et al. European Study Group on Classification Criteria for Sjögren's Syndrome: a revised version of the European criteria proposed by the American-European consensus group. Ann Rheum Dis 2002, 61:554-558.
71. Williams C.S., Butler E., Román G.C. Treatment of myelopathy in Sjögren syndrome with a combination of prednisone and cyclophosphamide. Arch Neurol 2001, 58:815-819.
72. Wright R.A., Grant I.A., Low P.A. Autonomic neuropathy associated with the sicca complex. J Auton Nerv Syst 1999, 75:70-76.